Nov 13th 2014

The Ethics of Fighting Ebola

PRINCETON – It may, in the end, turn out to be fortunate that a handful of people in developed countries – four in the United States and one in Spain – have contracted Ebola. Tragic as this was for Thomas Duncan, the only one of these patients who has died, if all of the more than 13,000 cases and nearly 5,000 deaths had occurred in Africa, Ebola would never have aroused nearly as much attention in rich countries.

In this respect, Ebola is – or, rather, was – an example of what is sometimes referred to as the 90/10 rule: 90% of medical research is directed toward illnesses that comprise only 10% of the global burden of disease. The world has known about the deadly nature of the Ebola virus since 1976; but, because its victims were poor, pharmaceutical companies had no incentive to develop a vaccine. Indeed, pharmaceutical companies could expect to earn more from a cure for male baldness. 

Government research funds in affluent countries are also disproportionately targeted toward the diseases that kill these countries’ citizens, rather than toward diseases like malaria and diarrhea that are responsible for much greater loss of life.

But the tiny number of Ebola cases in rich countries – and the ensuing panic-inducing headlines and quarantine measures – have brought home the global nature of infectious disease today. Mass travel has made effective containment of epidemics extremely difficult. 

The best defense against an infectious disease is to fight it where it originates, and that requires good health services. Ebola appears to have been eradicated from Nigeria, in no small part because that country had a Gates Foundation-supported hospital with personnel trained and equipped to control infectious diseases. If, over the past decade or two, affluent countries had done more to assist Liberia, Sierra Leone, and Guinea, the current Ebola outbreak could have been minimized, if not prevented.

But now it is too late for that, and scientists are rushing to find both a vaccine and an effective treatment for Ebola. What ethical considerations should guide them in their search? 

The standard way to judge the efficacy of a vaccine is to conduct a trial in which those who could benefit are randomly assigned to two groups, one of which receives the potentially beneficial vaccine, while the other receives a substance with no active ingredients, known as a placebo. To avoid possible confounding factors, such as greater risk-taking by those who know they have been vaccinated, or the desire of those conducting the trial to show that the vaccine works, the study is “double blind”: Neither the subjects nor those administering the trial and collecting the data know who got the vaccine and who got the placebo. Only an independent group examining the data sent in from the field has that information.

Without such a trial, the appearance of efficacy may be an illusion, because other factors would have led to a lower rate of infection anyway. Yet if a promising vaccine is available – and if safety trials in healthy human volunteers who are not at risk of infection demonstrate that it does no harm – to deny it to those who are tending to the sick and dying, at great risk to their own health, seems unethical. 

That question will soon need to be answered, because both the pharmaceutical giant GlaxoSmithKline (in conjunction with the US National Institute of Allergy and Infectious Diseases) and the Public Health Agency of Canada have candidate vaccines in development.

At a recent World Health Organization meeting in Geneva, Ripley Ballou, the head of GlaxoSmithKline’s program to develop a vaccine, argued that a randomized controlled trial comparing a potential Ebola vaccine with a vaccine that protects against another virus would be the most ethical way to assess efficacy. Depending on the outcome, results could be available within three months, allowing production and distribution to go ahead with greater confidence. 

Representatives of Médecins Sans Frontières (Doctors without Borders), which has more than 3,000 staff members combating Ebola in the most affected countries, strongly opposed giving placebos to anyone at high risk of contracting the disease. But Ballou appears to have persuaded many of the participants at the meeting that his proposal will save more lives in the long run. If that is true, a randomized controlled trial could be the most ethical option.

When it comes to treatment, the situation is different. In a letter published last month in The Lancet, doctors, scientists, and bioethicists from a wide range of countries – including Guinea, Ghana, Nigeria, and Senegal, as well as Britain, France, Hong Kong, and the United States – argued that a randomized trial is justified only when there is “equipoise,” or balance, between the two options offered. This can happen when doctors do not know whether a proposed treatment will do more harm than good, or when they are in doubt about which of two treatments is more likely to cure the patient. 

But, when facing a disease that kills up to 70% of those who are infected, and no accepted treatment yet exists, patients could reasonably refuse consent to a trial in which they might receive a placebo, rather than an experimental treatment that offers some hope of recovery. In such cases, it might be more ethical to monitor carefully the outcomes of different treatment centers now, before experimental treatments become available, and then compare these outcomes with those achieved by the same centers after experimental treatments are introduced. Unlike in a randomized trial, no one would receive a placebo, and it should still be possible to detect which treatments are effective.


Copyright: Project Syndicate, 2014.
www.project-syndicate.org




     

 


This article is brought to you by Project Syndicate that is a not for profit organization.

Project Syndicate brings original, engaging, and thought-provoking commentaries by esteemed leaders and thinkers from around the world to readers everywhere. By offering incisive perspectives on our changing world from those who are shaping its economics, politics, science, and culture, Project Syndicate has created an unrivalled venue for informed public debate. Please see: www.project-syndicate.org.

Should you want to support Project Syndicate you can do it by using the PayPal icon below. Your donation is paid to Project Syndicate in full after PayPal has deducted its transaction fee. Facts & Arts neither receives information about your donation nor a commission.

 

 

Browse articles by author

More Current Affairs

Jul 15th 2019
".....one of the most accurate recession indicators, known as the yield curve, has recently been flashing warning signs. Every postwar recession in the US was preceded by an inversion of the yield curve, meaning that long-term interest rates had fallen below short-term interest rates, some 12 to 18 months before the outset of the economic downturn."
Jul 6th 2019
Extract: ".........growing poverty even when working, the collapse of stable and safe social identities linked to work, the increasing instability of employment security, and the rapid change of local communities due to emigration, migration, collapsing housing affordability, and redevelopment initiatives that displace communities. These provide precise and urgent electoral rallying points. They are particularly effective given that so many mainstream politicians ignore these basic grievances. In recent years, the lineup of politicians opposing the New Right – Hillary Clinton, the Remain campaign, Emmanuel Macron and Matteo Renzi – have been unwilling to even recognise these structural problems. This provided the New Right the opportunity to appear credible, simply by acknowledging them."
Jul 6th 2019
".........an openly Russophilic administration in the US may be one reason why Putin’s domestic support has been declining so sharply."
Jul 3rd 2019
"Extract: .........in a world of rapidly expanding automation potential, demographic shrinkage is largely a boon, not a threat. Our expanding ability to automate human work across all sectors – agriculture, industry, and services – makes an ever-growing workforce increasingly irrelevant to improvements in human welfare. Conversely, automation makes it impossible to achieve full employment in countries still facing rapid population growth........The greatest demographic challenges therefore lie not in countries facing population stabilization and then gradual decline, but in Africa, which still faces rapid population growth."
Jul 1st 2019
Trump’s personal style – vocal, expertise-averse, scandal-prone and driven by a focus on his partisan base – may be unusual, but aspiring Democratic presidential contenders may be making a serious error in allowing Trump’s “Wizard of Oz” act of big claims and small achievements to pass unchallenged. There is a massive gap between the pledges he made to voters and the reality of an outsider presidency thoroughly co-opted by its party. So far, the “Trump revolution” turns out to be an ordinary Republican presidency.
Jun 25th 2019
"Trump’s vindictive bluster has steamrolled economic-policy deliberations – ignoring the lessons of history, rejecting the analytics of modern economics, and undermining the institutional integrity of the policymaking process. Policy blunders of epic proportion have become the rule, not the exception. It won’t be nearly as easy to spin the looming consequences."
Jun 19th 2019
Solar energy is one of the fastest-growing energy sectors in the world, and has the great advantage of producing no carbon dioxide, a greenhouse gas that is raising the average surface temperature of the earth. India is now for the first time in history investing more in solar energy than in coal. There is a simple reason for this. Coal costs roughly 5 cents a kilowatt hour to generate electricity. India just let a bid for 1.2 gigawatts of solar energy and four companies scooped it up at 3.6 cents a kilowatt hour.
Jun 19th 2019
Extract: "Abe has reportedly nominated Trump for a Nobel Peace Prize – at the request of the US – for opening talks with North Korea. And he has offered to mediate in America’s dispute with Iran. (His recent visit to Tehran – where he reportedly asked Iran’s leaders, at Trump’s request, to release detained Americans – made clear that, even squeezed by sanctions, Iran has no interest in negotiating with a serial violator of signed agreements.) What Trump calls an “incredible partnership” is, in reality, a largely one-sided relationship. But, for Abe, appeasing Trump is not so much a choice as a necessity: he must prove to Japan’s people and their neighbors, particularly the Chinese, that he knows how to keep Trump on his side."
Jun 17th 2019
Extarct: "We know well the damage that corrupt leaders do to their people. We should therefore have much more to say about the quintessential corruption entailed by tolerating lies. Such tolerance allows the poison to spread through the body and soul of democracy, undermining democracy’s institutions by attacking the invisible norms and tacit understandings that support them."
Jun 11th 2019
Extract: "I noticed this dynamic firsthand a few years ago in Blagoveshchensk, on the Siberian border, just a half-mile from the Chinese town of Heihe. A century and a half ago, Blagoveshchensk was part of China. Then the Cossacks took control of it, along with many other territories in Chinese Outer Manchuria, on behalf of the Russian czar. Blagoveshchensk’s local history museum presents the development of the town after the Cossack takeover as a civilizing mission. The Russians, it seems, still view themselves as superior Westerners. As for Heihe, it got rich a quarter-century ago, after capitalizing on Russia’s post-Soviet disarray to sell cheap goods to then-starving Russians. Its own history museum presents the Cossacks as “hairy barbarians” (Lao Maozi) and lists the towns of Russia’s far east by their historical Chinese names: Blagoveshchensk is Hailanpao, Vladivostok is Haishenwai, and Sakhalin is Kuye. Local behavior reflects these perspectives. At the ferry port, the Russians sneer at the Chinese traders who bring Russian vodka and chocolate to Heihe, while the Chinese move past the Russians as if they do not exist."
Jun 5th 2019
Extract: "....the Constitution, which established the impeachment process as a check on the president’s behavior between elections, says nothing about using it only when politically convenient. Moreover, given the results in 2018, Democratic Party leaders might well discourage making the disposition of the president the key issue in the next election. Most important, a decision not to initiate an impeachment process against Trump could set a terrible precedent. If Trump isn’t impeached for his numerous criminal acts and abuses of power, would impeachment remain a viable check on the presidency? "
Jun 3rd 2019
Extracts: "Sooner or later, all smaller powers dependent on global markets would have to choose a side, unless they are somehow strong enough to withstand both American and Chinese pressure. With China and the US both demanding clarity, even economic giants like the European Union, India, and Japan would be faced with an intractable economic dilemma."
May 24th 2019
Waging a war against Iran, or even thinking of doing so, is sheer madness. Trump has thus far wisely rejected the warmonger National Security Advisor John Bolton’s outrageous advice. Waging another war in the Mideast, this time against Iran, would have not only disastrous consequences for the US but will also engulf our allies from which they would suffer incalculable human losses and destruction. Bolton was the architect behind the devastating war in Iraq in 2003, which inflicted more than 5,000 US casualties and a cost exceeding two trillion dollars, allowed Iran to entrench itself in Iraq, and gave way to the rise of ISIS.
May 24th 2019
The private Tasnim news agency reports from Iran that in a speech to thousands of university students, Iran’s clerical leader Ali Khamenei made an unusual and extraordinary criticism of president Hassan Rouhani and foreign minister Mohammad Javad Zarif over their handling of the 2015 Joint Comprehensive Plan of Action or deal on limiting Iran’s nuclear enrichment program.
May 21st 2019
Extract: "Brexit, after all, is as much a Kremlin project as it is anyone else’s. Putin wants to divide Europeans, and in the UK, Brexit has succeeded in dividing Britons like nothing since the Corn Law debates almost 200 years ago. Putin wants the EU to fragment, and Brexit is causing the biggest crack yet in the bloc’s history. Putin wants to sow doubt about the legitimacy of traditional news sources; pro-Brexit media consistently promote lies as truth and inveigh against reputable papers like the Financial Times as elitist enemies of the people."
May 16th 2019
Iraq’s population when invaded was 26 million. Iran’s population today is 81 million..........Whereas Iraq’s neighbors– Turkey, Iran and Saudi Arabia in particular– had been mauled by Saddam and so did not strongly oppose Bush’s invasion, Shiite Iraqis, many Syrians, the Hazaras of Afghanistan, and the some 40 million Shiites of Pakistan would support Iran.
May 15th 2019
It’s time that economists, pundits, and politicians start looking holistically at life in our times, and take seriously the long-term structural changes needed to address the multiple crises of health care, despair, inequality, and stress in the US and many other countries. US citizens, in particular, should reflect on the fact that many other countries’ people are happier and less worried, and are living longer. In general, those other countries’ governments are not cutting taxes for the rich and slashing services for the rest. They are attending to the common good, instead of catering to the rich while pointing to illusory economic statistics that hide as much as they reveal.
May 8th 2019
"........Meanwhile, Trump is leaving the door open for Russia to come to his aid again in 2020. The White House and congressional Republican leaders have been blocking a bill to secure US elections against foreign attacks. And administration officials have been instructed not to raise the issue of Russian interference with the president, lest it cast a shadow on his legitimacy.  The next phase in this affair is already coming into focus. Barr, with the help of Trump’s golfing buddy Lindsey Graham, the Republican chair of the Senate Judiciary Committee, is now enlisted in peddling the president’s fantasy that the Mueller investigation was a “witch hunt” orchestrated by “deep-state” supporters of Hillary Clinton. Once again, current and former FBI agents will be targeted, either because they expressed criticism of Trump or because they opened a national security investigation into a hostile power’s meddling in the US presidential election (which continued in the 2018 midterms). FBI director Christopher Wray, commenting on the Mueller report, said that the Russians are “upping their game” for 2020. "
May 7th 2019
We are witnessing the loss of biodiversity at rates never before seen in human history. Nearly a million species face extinction if we do not fundamentally change our relationship with the natural world, according to the world’s largest assessment of biodiversity.